{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-044808","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.269612+00:00","generated_at":"2026-05-30T07:21:09.809128+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ADMA Biologics engages KPMG as new auditor effective after Q3 2024 10-Q filing","bullets":["KPMG appointed as independent registered public accounting firm on October 31, 2024, effective upon filing of Q3 2024 10-Q.","No consultations or disagreements with KPMG during prior fiscal years 2022-2023 and interim period through October 31, 2024.","KPMG will audit the consolidated financial statements for FY 2024, expected to be filed by March 3, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-044808","json":"https://secwatch.observer/filing/0001140361-24-044808.json","markdown":"https://secwatch.observer/filing/0001140361-24-044808.md","text":"https://secwatch.observer/filing/0001140361-24-044808.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124044808/0001140361-24-044808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124044808/ef20037117_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:21:09.809128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}